Massachusetts Life Sciences Center of Waltham, MA at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Massachusetts Life Sciences Center

1075 Main Street Suite 100, 02451 Waltham, MA
Telephone +1 781 3737777
Fax +1 781 6221530

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.


Jeanne LeClair

Director of Business Development

Waltham, Massachusetts, USA

(781) 296-7564


Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.07  Other diagnostics

Our products

Product category: Other diagnostics

Economic Development - Grant / Investment / Tax Incentive Programs

The Massachusetts Life Sciences Center’s portfolio of programs has strategically deployed more than $700 million in Massachusetts, through a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs. These investments have created thousands of jobs, and propelled the development of new therapies, devices, and scientific advancements that are improving patient health and well-being in Massachusetts and beyond.

More Less

Company news




Oct 28, 2020

Baker-Polito Administration Announces Awards for Massachusetts Life Sciences Center Initiative for Women Entrepreneurs

Six women-led, early-stage life sciences companies selected to receive non-dilutive capital and access to executive coaching network

Today, the Baker-Polito Administration and the Massachusetts Life Sciences Center (MLSC) announced the 2020 winners for the MLSC’s Massachusetts Next Generation Initiative (MassNextGen), a competitive program to support women entrepreneurs in early-stage life sciences companies. Six companies will receive more than $85,400 in funding and access to a network of executive coaches for a year. For this funding year, the MLSC and the program’s industry sponsors contributed $512,500 in funding for awards. Since inception, including this year’s awards, the MLSC has deployed more than $1 million in funding for women entrepreneurs through MassNextGen with an executive coaching network providing 200-plus hours of coaching.

“This dynamic group of entrepreneurs and the companies they lead are an essential pillar of our innovative and thriving life sciences sector,” said Lt. Governor Karyn Polito. “The Baker-Polito Administration is committed to providing the tools and other resources to ensure the success of women at all levels in our innovation economy, with a hyper-focus on STEM-oriented fields.”

MassNextGen is a five year, more than $2 million commitment to ensure greater gender parity in the next generation of life science entrepreneurs. Each year, following a competitive program, the MLSC awards women-led early-stage life science companies a yearlong customized package of support, which includes non-dilutive grant funding and access to a network of seasoned Executive Coaches from the life sciences ecosystem to refine their business strategies and effectively raise capital. Lt. Governor Polito formally announced the 2020 awardees via a celebratory video message.

“The Life Sciences Center continues to play a unique role in developing and executing new strategies to address persistent unfairness toward female entrepreneurs in this vital industry,” said Massachusetts Housing & Economic Development Secretary Mike Kennealy, who serves as Co-Chair of the MLSC Board of Directors. “Producing a more diverse workforce and empowering more women entrepreneurs is essential for Massachusetts to retain its global leadership in the life sciences industry.”

“Ensuring women have equal representation will further accelerate the output of innovative ideas and developments in this thriving sector,” said Secretary for Administration and Finance Michael J. Heffernan, who serves as Co-Chair of the MLSC Board of Directors. “Supporting a strong and diverse environment of early-stage companies is a smart business strategy and consistent with the Baker-Polito  Administration’s robust commitment to attract and retain top talent in Massachusetts.”

The six women-led companies selected as awardees through the third year of the MassNextGen program represent a wide range of applications to improve human health. This year’s awardees are:

Axonis, Inc.
MassNextGen Entrepreneur: Joanna Stanicka, CEO
Advancing breakthrough drug discoveries to develop groundbreaking therapies for spinal cord injury and other currently incurable neurological disorders, making a real difference for patients, their families, and the global healthcare system

MassNextGen Entrepreneur: Natalie Artzi, Co-Founder and CEO
Aiming to transform the field of surgical and topical adhesive materials with a family of proprietary internal, external and reversible adhesive materials that reacts in a graded manner with each tissue as a function of type and state to provide adequate adhesion while maintaining biocompatibility

Ernest Pharmaceuticals
MassNextGen Entrepreneur: Nele van Dessel, Co-Founder and CEO
The vision of Ernest Pharmaceuticals is to create a new bacterial toolbox for cancer therapies that will increase translation of cutting-edge discoveries in fundamental cancer research into clinical treatments. Ernest Pharmaceuticals’ focus will be on tumors with low survival rates, such as liver, pancreas, ovarian and metastatic breast cancer. For these patients, very few therapeutic possibilities exist that greatly improve overall survival time. Bacterial cancer therapies have the potential to change these high mortality rates and to make a significant impact in the lives of patients that have exhausted all treatment options.

New Equilibrium Biosciences
MassNextGen Entrepreneur:Virginia Burger, Co-Founder and CEO
Building a computational-experimental platform that will empower the discovery of drugs targeting a class of proteins implicated in most cancers and neurodegenerative diseases, but for which no drugs have been successfully developed

PionEar Technologies
MassNextGen Entrepreneur: Ida Pavlichenko, CEO, President, and Co-Founder
Developing a new generation of fluid-guiding, and biocontamination-resistant medical conduits (e.g. tubes and shunts) that can be customized to address the need for more efficacious drug delivery or drainage of biological fluids in different parts of the human body. PionEar’s first product is a bioinspired tympanostomy tube (also known as an ear tube) that allows antibiotic drops to penetrate the middle ear more efficiently than existing tubes for a more effective resolution of infection and reduces the risk of unnecessary revision surgeries and complications.

Seaspire (J&J Awardee)
MassNextGen Entrepreneur: Camille Martin, CEO
Pioneering a new category of multifunctional materials utilizing the  bio-inspired, patent-pending, natural ingredient Xanthochrome® to combat negative health implications associated with environmental pollution.

“Now more than ever, the sustaining of the Massachusetts’ leadership post in the life sciences requires an increased sense of urgency for a more diverse workforce which empowers more women in the field,” said MLSC interim President and CEO Damon Cox. “Women are essential members of an innovative and thriving ecosystem and the MLSC remains committed to providing the tools necessary in order for them to succeed, thereby providing an opportunity for Massachusetts to gain a competitive advantage by having women equally represented.”

Increasing the number of successful entrepreneurs is in the best interest of the entire life science industry and as such, this initiative is a public-private partnership between the Massachusetts Life Sciences Center, Sanofi, King Street Properties, and the initiative’s initial corporate sponsor, Takeda.

“As one of the inaugural sponsors of the MassNextGen Initiative, Takeda is honored to partner with the MLSC and the Baker-Polito administration on this important program,” said Ramona Sequeira, President of Takeda’s US Business Unit and Global Portfolio Commercialization. “Women bring unique ideas and experiences to the entrepreneurial process and this diversity is critical for driving access to innovative medicines and care, supporting patients, and addressing health disparities in our communities.”

“At Sanofi we have a long, and proud, history of Community Engagement in the areas of health equity, STEM education, inclusion and diversity, and community needs,” said Rachel Sha, Vice President, Digital Strategy and Governance at Sanofi. “We believe that everyone deserves an equal opportunity to thrive, to be healthy and to be part of a flourishing community. We are proud to support MassNextGen in its efforts to empower female entrepreneurs in Massachusetts. Now, more than ever, we all have a responsibility to step up to bring about meaningful change.”

“We are more committed than ever to providing support to the life science economy in Massachusetts,” said King Street Properties Principal Steve Lynch on behalf of himself and his co-Principal Tom Ragno. “MassNextGen’s focus on inclusiveness and entrepreneurship matches perfectly with our own corporate values and the times we live in. Harnessing the full potential of women in the life science community has never been more important.”

This past September, the MLSC announced Johnson & Johnson Innovation as the newest sponsor for MassNextGen. The funding provided to the public-private strategic partnership allows Johnson & Johnson Innovation to define a “J&J Awardee” of which Seaspire was selected to participate.

Now with 16 companies in its portfolio, MassNextGen continues toward its goal of shifting the paradigm to build a diverse ecosystem with equal representation. As MassNextGen Entrepreneurs and their respective teams work toward new innovative therapeutics and products for patients, MLSC funding and executive coaching mentorship have proven invaluable for these women entrepreneurs in building their teams and progressing forward with new opportunities. First-year awardee Olaris closed its Series A funding round in September 2019, now employing a team of seven. Fellow first-year awardee, Reveal Pharmaceuticals received a Fast-Track Small Business Innovation Research (SBIR) award from the National Cancer Institute. Second-year awardee Envision Endoscopy completed critical prototyping, while also receiving SBIR funding. Additionally second-year awardees, PhagePro and LivOnyx, were able to make critical hires, while Lucy Therapeutics received a Golden Ticket at LabCentral and See Yourself Health has executed key partnerships putting them in a better position to add to customers and partners.

The announcement of the 2020 MassNextGen awardees follows a series of announcements and new program rounds from the MLSC related to capital programming, its Seed Fund, and most recently the launch of a new $3.6 million funding initiative, Accelerating Coronavirus Testing Solutions (A.C.T.S.), to increase testing capacity and address gaps that currently exist in coronavirus testing.

More Less

Oct 23, 2020

Massachusetts Life Sciences Center Announces STEM Equipment and Professional Development Grants for Chelsea and Randolph School Districts

Life Sciences Center awards more than $330,000 in funding to benefit 3,500+ middle school and high students in Chelsea and Randolph

Today, the Massachusetts Life Sciences Center (MLSC) announced two separate STEM equipment and teacher professional development grants for Chelsea and Randolph public schools. The more than $330,000 in funding, which will serve 3,500-plus students, supports the purchase of necessary lab equipment and supplies, as well as state-of-the-art tools and technology to better train and prepare students for life sciences careers, while also enabling teachers from multiple schools to participate in professional development opportunities. Chelsea Public Schools is receiving $194,237 ($100,537 for equipment and supplies and $93,700 for professional development) and Randolph Public Schools is receiving $137,173 ($91,973 for equipment and supplies and $45,200 for professional development).

“Our Administration is committed to strengthening and expanding pathways for students to experience STEM in schools across Massachusetts,” said Lt. Governor Karyn Polito. “With a focus on educational equity in life sciences instruction and training, this funding will unlock new opportunities for Massachusetts students to see themselves in a STEM-focused career.”

“The Baker-Polito Administration remains committed to investments in new opportunities for Massachusetts students to learn, gain skills, and drive interest in a career in the life sciences,” said Massachusetts Housing & Economic Development Secretary Mike Kennealy, who serves as Co-Chair of the MLSC Board of Directors. “Through a shared goal to increase exposure and experiential opportunities in STEM, students are able to engage in hands-on learning early-on for success at the middle and high school levels, while also strengthening the future Massachusetts workforce.”

“The Baker-Polito Administration is committed to strengthening and expanding the Commonwealth’s life sciences talent pipeline by increasing opportunities for students to become involved with STEM,” said Secretary for Administration and Finance Michael J. Heffernan, who serves as Co-Chair of the MLSC Board of Directors. “These grants are an investment in the next generation of problem solvers, providing young people the necessary tools and dynamic space necessary to compete for exciting jobs in industries that will continue to grow and make a difference in people’s lives.”

Both school districts will use the grant funding to implement new curriculum provided by the Massachusetts Biotechnology Education (MassBioEd) Foundation. MassBioEd’s Aligned Curricular and Career Experiences in Secondary Science (ACCESS) program seeks to create a strong foundation of scientific learning and thinking that improves MCAS performance, engages students in critical thinking, develops problem-solving skills, and provides career awareness.

“The thousands of students these funds will serve represent the inspiring young people across Massachusetts who hold the key to our Commonwealth remaining home to the most robust talent pool in the country,” said Interim MLSC President and CEO Damon Cox. “The Life Sciences Center continues to be a robust partner to our k-12 partners to ensure that as many students as possible are provided hands-on learning to grow their curiosity, skills, and knowledge in various STEM fields.”

The Chelsea Public Schools grant will support four schools, Chelsea High School and all three Chelsea middle schools, with equipment, utilized by approximately 2,271 students annually, and professional development for 27 teachers. Grant funds will also fund augmented reality equipment for students to engage in more complex or invisible phenomena through partially or fully immersive experiences. The expected outcome from receiving the grant will be more robust curriculum units that incorporate hands-on, authentic learning experiences that will support students to understand phenomena in the natural world.

“We are very excited to be able to offer our students a deeper learning experience in the life sciences,” said Chelsea Public Schools Superintendent Dr. Almi G. Abeyta. “With the grant from the Massachusetts Life Sciences Center we will be able to provide students with meaningful hands-on and augmented reality labs which will help to set the foundation for many of them to enter the life sciences workforce in the years to come.”

“The Mass Life Sciences Center’s grant to the Chelsea Public Schools is great news for the district, and will avail our middle and high school students to a wider, more hands-on, and up-to-date STEM curriculum,” said Senator Sal DiDomenico. “The continued partnership our school districts have with the Life Sciences Center helps to inspire interest and passion for STEM among our students and further supports the professional development of our STEM faculty.”

“Thank you to the Massachusetts Life Sciences Center for awarding Chelsea Public Schools these grants totaling nearly $200,000 for equipment and professional development in STEM,” said Representative RoseLee Vincent (D-Revere).  “Providing these expanded educational opportunities to students in middle school will help to spark and foster an interest in STEM in our students and could place them onto the path for a bright and successful future in the STEM field.”

“I want to thank the Mass Life Sciences Center for their investment in the young people of Chelsea,” said State Representative Dan Ryan. “These grants will go a long way in advancing STEM learning and student opportunities in Chelsea so our students will have the tools and skills to compete in a leading Massachusetts industry if they choose to do so.”

“We are grateful to the Massachusetts Life Sciences Center for providing this grant to Chelsea’s schools,” said Chelsea City Manager Tom Ambrosino. “Investments in equipment and teachers’ professional development for our STEM programming will help ensure our schools better serve students as they prepare for careers in life sciences and beyond.”

The grant to Randolph Public Schools will support both the district’s high school and middle school with equipment, utilized by approximately 1,312 students annually, and professional development for 12 teachers. Funding will also enable the district to receive MassBioEd’s job-embedded professional development, form connections with experts in the field, and bring hands-on lab science experiences in the classrooms.

“Randolph High School is extremely excited about this partnership with Mass Life Sciences,” said Randolph High School Assistant Principal David Pierce. “We see this grant as an opportunity for both our teachers and our students as we work to provide a high level of science instruction and science pathways to future careers.”

“Through this outstanding grant from the Massachusetts Life Science Center, the investment into the STEM program in Randolph will provide students with new lab equipment and supplies,” said State Senator Walter F. Timilty. “This is not only an investment in the school district, but also an investment for our future. I’m so very thankful to the Life Science Center for this wonderful investment.”

“This is tremendous news. I saw firsthand the reach of this grant program as part of the House Bonding Committee last session,” said State Representative Bill Driscoll Jr. “I thank the Massachusetts Life Sciences Center and their leadership for recognizing Randolph Public Schools with this important investment.”

“We’re grateful to the Massachusetts Life Sciences Center for making this grant and the support it provides possible,” said Randolph Town Manager Brian Howard. “It’s an investment in the curiosity and professional development of Randolph students and teachers that will open new doors toward careers in STEM-related fields.”

The MLSC has now invested more than $17.8 million in equipment and professional development funding in nearly 200 high schools, middle schools, and organizations throughout Massachusetts, and has leveraged more than $1 million in cash and in-kind matching funds from industry partners. MLSC funding has served schools in 13 of the 14 Massachusetts counties and 25 of the 26 Gateway Cities. Moreover, more than half of students attending eligible schools have gained access to new equipment and nearly 30 percent of all Massachusetts public school students attend a school that has received an MLSC grant.

More Less

Oct 15, 2020

Baker-Polito Administration Announces $6.5 Million in New Manufacturing Emergency Response Team Grants

Thirteen Projects Will Produce Masks, Hand Sanitizer, Gowns; Boost Testing

The Baker-Polito Administration has awarded over $6.5 Million to 13 Massachusetts organizations to develop new products to assist in the response to the COVID-19 public health emergency. The new grants from the Massachusetts Manufacturing Emergency Response Team (MERT) will expand the Commonwealth’s work to drive in-state manufacturing of critical products, an effort which has produced more than 11 million pieces of personal protective equipment and other critical pieces as of September.

The new grants, announced during national Manufacturing Month, bring the total MERT awards to $16.2 million, and have spurred the production of critical items including N95 masks, protective gowns, hand sanitizer, and ventilators. Since its inception, the MERT has mobilized, organized, and operationalized the critical work streams that allowed Massachusetts manufacturers to pivot their operations to produce needed materials in response to the COVID-19 pandemic. The new awards support infrastructure and workforce training efforts at each company, driving increased production from these ‘Made in Massachusetts’ manufacturers.

“The MERT program continues to identify and support successful ‘Made in Massachusetts’ manufacturers that produce Personal Protective Equipment for our front-line responders, business owners, and residents,” said Governor Charlie Baker.“This program and the sheer output from these manufacturers has been central to the Commonwealth’s fight against COVID-19.”

“Our administration is pleased to support these capital and workforce training requests to ensure Massachusetts’ manufacturing sector will continue to produce in the face of these tough economic times,” said Lt. Governor Karyn Polito. “As we emerge from this public health crisis, our hope is that these new product lines spur job creation and drive growth for these companies, while also establishing new supply chains for our in-state purchasers of PPE.”

“As the chair of the Advanced Manufacturing Collaborative, I couldn’t be prouder to support these grantees, and to remind people across the nation and world that we make things here in Massachusetts,” said Secretary of Housing and Economic Development Mike Kennealy. “Not only has this new home-grown production of PPE benefited those battling this virus on the frontlines, but it has also contributed to our ability to safely reopen the Commonwealth’s economy.”

“The Commonwealth has the most educated and best-trained workforce in the U.S.,” said Secretary of Labor and Workforce Development Rosalin Acosta. “These grants will allow Massachusetts to tap into that unparalleled advanced manufacturing talent pool and help to provide the equipment that workers in industries across the Commonwealth are depending on.” 

Launched in April 2020, the MERT grant program made its first set of awards in May 2020, when it provided $9.5 million to 15 Massachusetts organizations that are now producing masks, gowns, ventilators, swabs, and testing materials, as well as boosting the capacity to test these critical items. The MERT grants support the purchase of equipment, working capital, materials, and workforce development efforts with funding provided by a partnership that includes the Executive Office of Housing and Economic Development, Massachusetts Technology Collaborative (MassTech), Massachusetts Life Sciences Center, Commonwealth Corporation, and the Massachusetts Manufacturing Innovation Initiative (M2I2).

“The companies supported by the MERT have produced millions of pieces of PPE and set themselves apart nationally for the speed and efficiency with which they put these critical items into the hands of front line workers,” said Carolyn Kirk, Executive Director of MassTech. “We’ve seen similar trends with our first set of grantees, who’ve taken the state funding and made huge gains in a short amount of time. It’s been an honor to lead the MERT and to work with our partners to help these companies.”

“The Life Sciences Center is proud to be part of this continued effort to provide the necessary support to manufacturers located throughout the Commonwealth,” said Damon Cox, Interim President and CEO of the Massachusetts Life Sciences Center.“The MERT represents the Commonwealth’s collaborative DNA in action as academic, industry, and government stakeholders remain steadfast in their commitment to work together to leverage resources and expertise to respond to the COVID-19 pandemic.”

“Our grant programs are designed to provide workers with the skills they need for lifelong careers and today we are also providing a lifeline to our dedicated frontline workers,” said Commonwealth Corporation CEO and President Christine Abrams. “This grant program has been critical to the Commonwealth’s recovery from the impact of the coronavirus, while supporting the pivot of manufacturers impacted by the pandemic, bolstering the stabilization of the Massachusetts economy.”

“AFFOA is proud to be working with the MERT and facilitating the strategic investments being made into manufacturing across the Commonwealth,” said Sasha Stolyarov, Ph.D., Chief Executive Officer of Advanced Functional Fabrics of America (AFFOA). “Our domestic manufacturing ecosystem is more robust and resilient today thanks to the forward-thinking vision of the MERT and the innovative spirit of our manufacturers.”

Of the $16.1 million awarded through the MERT grant program:

$7.2 million to support the development of protective masks (45 percent of the total);
$3.2 million for COVID-19 testing (20 percent);
$3.2 million for gowns (20 percent);
$1.4 million for ventilators;
$630,000 for testing of PPE;
$341,000 for hand sanitizer; and
$257,000 for support of materials/supply chain.
The MERT is a coordinated effort comprised of members from academia, industry, and government to address the urgent need for PPE to support health care workers on the front lines of Massachusetts’ COVID-19 response. More than 900 companies from around the world submitted their interest to the MERT, including over 550 from Massachusetts.  Of those, over 50 companies have made it through the program, producing hundreds of thousands of pieces of PPE and other critical items each week, totaling more than 11 million since the start of the pandemic. Managed by MassTech, the quasi-public economic development agency that oversees advanced manufacturing programs for the Commonwealth, the MERT was devised as an emergency response to the COVID-19 pandemic and will continue to assist manufacturers in targeted ways as the demand for PPE continues.

More Less

Oct 6, 2020

Baker-Polito Administration announces $3.6 million program to accelerate development of Coronavirus testing solutions

Massachusetts Life Sciences Center to administer new Accelerating Coronavirus Testing Solutions Program to develop rapid, innovative ‘at-home’ or point-of-care testing methods and mitigate current supply chain barriers

Today, the Baker-Polito Administration announced a new $3.6 million funding initiative to increase testing capacity and address gaps that currently exist in coronavirus testing. The Accelerating Coronavirus Testing Solutions (A.C.T.S.) Program, designed and administered by the Massachusetts Life Sciences Center (MLSC), will fund projects focused on two core areas: one, accelerating the development of at-home or point-of-care testing methods that are simpler and more rapid, and two, new and innovative solutions that address existing supply chain barriers. The MLSC’s Request for Proposals is open to for-profit companies and not-for-profit institutions; teams working on solutions that provide low-cost, surveillance testing technology that can be deployed independent of Clinical Laboratory Improvement Amendments (CLIA) or medical personnel are encouraged to apply.

While Massachusetts has had a number of successes in supporting manufacturing through the Manufacturing Emergency Response Team (M-ERT), this program seeks to further refine the focus on remaining supply chain bottlenecks.  From identifying ways to increase manufacturing capacity, to the development of specialized materials, this program will support critical areas of need to allow labs across the Commonwealth to fully utilize and leverage their existing high throughput testing platforms.

An application should provide solutions that significantly increase testing capacity, and may address a well-defined issue beyond an identified priority area, but must articulate the positive impact on coronavirus testing. The MLSC with assistance from an advisory panel will evaluate proposals based on an effort’s ability to address and execute in a defined priority area; time to patient and/or implementation success, ability to leverage additional resources (e.g. funding, supplies, equipment) of the Massachusetts life sciences industry cluster; probability of scaling in Massachusetts; and potential to drive economic development and contribute to larger ecosystem in the Commonwealth.

The MLSC will accept applications on a rolling basis with evaluations taking place in two-week cycles. Applications for the first cycle will close on October 16, 2020 at noon EST. Subsequent cycles will close every two weeks after that point.

In recent months, the MLSC has been proud to be part of the Commonwealth’s ongoing effort to respond to the COVID-19 outbreak, including contributing funding and resources to the M-ERT and the Massachusetts Consortium on Pathogen Readiness. These recent contributions are in addition to the Center’s continued administration of various programs and other initiatives to support the life sciences sector. At the onset of the COVID-19 pandemic, the MLSC’s Board of Directors authorized an expenditure of $5 million from the Center’s Investment Fund and $5 million from its Capital Fund to support academic and/ or industry partners engaged in responding to the imminent public health threat. While the A.C.T.S. program is currently capitalized with $3.6 million, the MLSC is prepared to deploy additional funds to support A.C.T.S. and other efforts part of the Commonwealth’s broader response.

More Less

About us

Company details

The Massachusetts Life Sciences Center is an economic development and investment agency with a mission of supporting the growth and development of the life sciences in Massachusetts.

Through public-private funding initiatives, the Massachusetts Life Sciences Center supports innovation, research and development, commercialization, and manufacturing activities in the fields of biopharma, medical device, diagnostics, and digital health.  As a quasi-public agency, Massachusetts Life Sciences Center also offers programs that fund innovation-driven economic and workforce development initiatives in Massachusetts.

The Massachusetts Life Sciences Center’s mission is to serve as the “hub” of the Massachusetts life sciences ecosystem, encourage innovation through investments in good science and good business, strengthen and protect Massachusetts’ global leadership position in the life sciences, accelerate the commercialization of promising treatments, therapies, and cures that will improve patient care, and create jobs and drive economic and STEM workforce development.

More Less

Company data

Sales volume

100-199 Mio US $